ALLIOSPHARMA identifies and selects prebiotics and plant-based leads (molecules, extracts) with proven pharmacological and prior human usage/clinical activity.
Leads selected by ALLIOSPHARMA are both ethical drug and evidence-based nutraceutical (EBN) candidates. ALLIOSPHARMA positions and develops these products -up to phase I/II for ethical drug candidates- in order to maximize commercial and regulatory approval potential
